Treatment of COVID‐19 with pentoxifylline: could it be a potential adjuvant therapy?
The world is facing a viral pandemic of a new coronavirus called COVID‐19. Pentoxifylline is
a methyl‐xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
a methyl‐xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?
F Seirafianpour, S Mozafarpoor… - Dermatologic …, 2020 - pubmed.ncbi.nlm.nih.gov
The world is facing a viral pandemic of a new coronavirus called COVID-19. Pentoxifylline is
a methyl-xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
a methyl-xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
Treatment of COVID‐19 with pentoxifylline: Could it be a potential adjuvant therapy?
F Seirafianpour, S Mozafarpoor, N Fattahi… - Dermatologic …, 2020 - search.ebscohost.com
The world is facing a viral pandemic of a new coronavirus called COVID‐19. Pentoxifylline is
a methyl‐xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
a methyl‐xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
[PDF][PDF] Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?
F Seirafianpour, S Mozafarpoor, N Fattahi… - researchgate.net
The world is facing a viral pandemic of a new coronavirus called COVID-19. Pentoxifylline is
a methyl-xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
a methyl-xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
[HTML][HTML] Treatment of COVID‐19 with pentoxifylline: Could it be a potential adjuvant therapy?
F Seirafianpour, S Mozafarpoor, N Fattahi… - Dermatologic …, 2020 - ncbi.nlm.nih.gov
The world is facing a viral pandemic of a new coronavirus called COVID‐19. Pentoxifylline is
a methyl‐xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
a methyl‐xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?
F Seirafianpour, S Mozafarpoor, N Fattahi… - Dermatologic …, 2020 - europepmc.org
The world is facing a viral pandemic of a new coronavirus called COVID‐19. Pentoxifylline is
a methyl‐xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
a methyl‐xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
Treatment of COVID-19 with pentoxifylline: could it be a potential adjuvant therapy?
F Seirafianpour, S Mozafarpoor, N Fattahi… - 2020 - cabidigitallibrary.org
The world is facing a viral pandemic of a new coronavirus called COVID-19. Pentoxifylline is
a methyl-xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
a methyl-xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
[PDF][PDF] Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?
F Seirafianpour, S Mozafarpoor, N Fattahi… - researchgate.net
The world is facing a viral pandemic of a new coronavirus called COVID-19. Pentoxifylline is
a methyl-xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …
a methyl-xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is …